Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimal systemic therapy for high-risk resectable melanoma
Alexander M.M. Eggermont, Omid Hamid, Georgina V. Long, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 7, pp. 431-439
Closed Access | Times Cited: 18

Showing 18 citing articles:

Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
Georgina V. Long, Alexander M. Menzies, Richard A. Scolyer
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3236-3248
Closed Access | Times Cited: 43
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Mark Lawler, Lynne Davies, Simon Oberst, et al.
The Lancet Oncology (2022) Vol. 24, Iss. 1, pp. e11-e56
Open Access | Times Cited: 68
Debating Sentinel Lymph Node Biopsy for Melanoma in the Modern Adjuvant Era
Xiaoran Zhang, Laura K. Ferris, Mark B. Faries, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 26, pp. 4204-4207
Closed Access | Times Cited: 7
Tumor-infiltrating lymphocytes for melanoma immunotherapy
Oliver Kepp, Peng Liu, Laurence Zitvogel, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
Anna Maria Di Giacomo, Michael Lahn, Alexander M.M. Eggermont, et al.
European Journal of Cancer (2023) Vol. 198, pp. 113501-113501
Open Access | Times Cited: 5
CXCL10-coronated thermosensitive “stealth” liposomes for sequential chemoimmunotherapy in melanoma
Xiaofei Xin, Yong Zhou, Jingjing Li, et al.
Nanomedicine Nanotechnology Biology and Medicine (2022) Vol. 48, pp. 102634-102634
Closed Access | Times Cited: 8
Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Shanbao Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Immunotherapy in Melanoma: Highlights for the General Practitioner
Assma Ben Aïssa
Praxis (2023) Vol. 112, Iss. 3, pp. 135-142
Closed Access | Times Cited: 2
Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis
Zuhui Pu, Qing Zhao, Jiaqun Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Progression/Recurrence-Free Survival 2 in Adjuvant Melanoma
Ryan C. Augustin, Jason J. Luke
NEJM Evidence (2022) Vol. 1, Iss. 11
Closed Access | Times Cited: 3
EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma
Fuyuan Liu, Weikang Wu, Weiwei Cao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167336-167336
Closed Access
The emergence of neoadjuvant immune‐over BRAF therapy in melanoma
Elisa A. Rozeman, Jason J. Luke
Cancer (2024) Vol. 130, Iss. 20, pp. 3409-3411
Closed Access
Annals of Surgical Oncology Practice Guidelines Series: Adjuvant and Neoadjuvant Therapy for Melanoma
Jeffrey M. Farma, Anthony J. Olszanski, Jane L. Messina, et al.
Annals of Surgical Oncology (2024)
Open Access
FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells
Yaqi Wang, Hui Su, Xiaopeng Wang, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2505-2518
Open Access
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP–MADAM (Maximing ADjuvAnt MAP): Interim Analysis
Francesca Consoli, Marco Tucci, Jacopo Pigozzo, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4072-4072
Open Access
The Use of Liver Support System Devices in Acute Liver Failure as a Consequence of Metastatic Melanoma in the Liver: A Case Report and Review of the Literature
Ana Marija Bukovica, Thomas G. Salopek, Iva Skočilić, et al.
Case Reports in Oncology (2024) Vol. 18, Iss. 1, pp. 7-14
Open Access
Induction Exposure Dose of Ipilimumab and Failure of Adjuvant Nivolumab Plus Ipilimumab in Melanoma
Ryan C. Augustin, Jason J. Luke
Journal of Clinical Oncology (2022) Vol. 41, Iss. 3, pp. 443-446
Open Access | Times Cited: 2
Autoantibodies as Predictors for Clinical Outcome and Toxicity for Immunotherapy
Jessica C. Hassel, Jason J. Luke
Clinical Cancer Research (2022) Vol. 28, Iss. 18, pp. 3914-3916
Open Access | Times Cited: 1
Page 1

Scroll to top